Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Syncona Limited LSE:SYNC London Ordinary Share GG00B8P59C08 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 184.80 182.00 185.00 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 25.4 15.5 2.3 79.0 1,237

Syncona Limited Issue of shares pursuant to incentive scheme

15/07/2022 7:00am

UK Regulatory (RNS & others)


Syncona (LSE:SYNC)
Historical Stock Chart


From May 2022 to Nov 2022

Click Here for more Syncona Charts.

TIDMSYNC

RNS Number : 5790S

Syncona Limited

15 July 2022

Syncona Limited

Issue of shares pursuant to incentive scheme and PDMR dealings

15 July 2022

Syncona Ltd (the "Company"), a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life science, today announces that a total of 2,595,736 new ordinary shares (representing 0.39% of the Company's existing issued ordinary shares) will be issued in satisfaction of realisations under the Company's long term incentive scheme. The new ordinary shares, when issued, will rank pari passu with the existing issued ordinary shares of the Company. In accordance with the rules of the incentive scheme, the number of ordinary shares to be issued has been calculated using the closing mid-market price on 13 July 2022, GBP1.964.

In accordance with the rules of the incentive scheme, ordinary shares delivered on realisation may not be sold or transferred by the recipient for a period of one year following the realisation date.

The issue of shares include the following shares to be issued to senior members of the Syncona Investment Management Limited (SIML) leadership team:

 
 Name               SIML Title                  No. of shares to be 
                                                 issued 
 Martin Murphy      Chief Executive Officer     993,527 
                   --------------------------  -------------------- 
 Chris Hollowood    Chief Investment Officer    642,815 
                   --------------------------  -------------------- 
 

Application will be made to the Financial Conduct Authority for the shares to be admitted to the Official List, and to the London Stock Exchange for the shares to be admitted to trading and it is expected that dealings will commence in the new ordinary shares on 20 July 2022.

Following admission, the Company will have 669,329,324 ordinary shares in issue and the total number of voting rights in the Company will be 669,329,324 . The Company does not hold any ordinary shares in treasury. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interests in, the Company under the FCA's Disclosure and Transparency Rules.

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs") are set out below.

[ENDS]

Enquiries

Syncona Ltd

Natalie Garland-Collins / Fergus Witt

Tel: +44 (0) 7714 916615

About Syncona

Syncona's purpose is to invest to extend and enhance human life. We do this by founding and building companies to deliver transformational treatments to patients in areas of high unmet need.

Our strategy is to found, build and fund companies around exceptional science to create a diversified portfolio of 15-20 globally leading healthcare businesses, across development stage and therapeutic areas, for the benefit of all our stakeholders. We focus on developing treatments for patients by working in close partnership with world-class academic founders and management teams. Our balance sheet underpins our strategy enabling us to take a long-term view as we look to improve the lives of patients with no or poor treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders.

Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com

 
 1.   Details of PDMR / person closely associated with them 
       ("PCA") 
 a)   Name                   Martin Murphy 
     ---------------------  ---------------------------------------- 
 b)   Position /             Chief Executive Officer, SIML 
       status 
     ---------------------  ---------------------------------------- 
 c)   Initial notification   Initial Notification 
       / amendment 
     ---------------------  ---------------------------------------- 
 2.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     --------------------------------------------------------------- 
 a)   Description            Ordinary shares 
       of the financial       GG00B8P59C08 
       instrument 
     ---------------------  ---------------------------------------- 
 b)   Nature of              Issue of shares pursuant to the Syncona 
       the transaction        long term incentive scheme 
     ---------------------  ---------------------------------------- 
 c)   Price(s) and            Price(s)    Volume(s) 
       volume(s)                GBP1.964    993,527 
     ---------------------  ---------------------------------------- 
 d)   Aggregated 
       information 
       Aggregated              N/A 
       volume 
       Price 
     ---------------------  ---------------------------------------- 
 e)   Date of the            14 July 2022 
       transaction 
     ---------------------  ---------------------------------------- 
 f)   Place of the           Outside a trading venue 
       transaction 
     ---------------------  ---------------------------------------- 
 g)   Currency               GBP - British Pound 
     ---------------------  ---------------------------------------- 
 
 
 1.   Details of PDMR / person closely associated with them 
       ("PCA") 
 a)   Name                   Chris Hollowood 
     ---------------------  ---------------------------------------- 
 b)   Position /             Chief Investment Officer, SIML 
       status 
     ---------------------  ---------------------------------------- 
 c)   Initial notification   Initial Notification 
       / amendment 
     ---------------------  ---------------------------------------- 
 2.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     --------------------------------------------------------------- 
 a)   Description            Ordinary shares 
       of the financial       GG00B8P59C08 
       instrument 
     ---------------------  ---------------------------------------- 
 b)   Nature of              Issue of shares pursuant to the Syncona 
       the transaction        long term incentive scheme 
     ---------------------  ---------------------------------------- 
 c)   Price(s) and            Price(s)    Volume(s) 
       volume(s)                GBP1.964    642,815 
     ---------------------  ---------------------------------------- 
 d)   Aggregated 
       information 
       Aggregated              N/A 
       volume 
       Price 
     ---------------------  ---------------------------------------- 
 e)   Date of the            14 July 2022 
       transaction 
     ---------------------  ---------------------------------------- 
 f)   Place of the           Outside a trading venue 
       transaction 
     ---------------------  ---------------------------------------- 
 g)   Currency               GBP - British Pound 
     ---------------------  ---------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEUSRORUWUBAUR

(END) Dow Jones Newswires

July 15, 2022 02:00 ET (06:00 GMT)

1 Year Syncona Chart

1 Year Syncona Chart

1 Month Syncona Chart

1 Month Syncona Chart
Your Recent History
LSE
SYNC
Syncona
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20221128 08:00:27